P16.05 Real World Data of First-Line Treatment With Pembrolizumab for Highly PD-L1-Expressing NSCLCM. Kobayashi, H. Mizugaki, Y. Ikezawa,R. Morita,K. Tateishi,K. Yokoo,T. Sumi,H. Kikuchi, Y. Nagano,A. Nakamura,M. Aso,N. Kimura,F. Yoshiike,M. Furuta,H. Tanaka, M. Sekikawa,T. Hachiya,Y. Fujita,S. OizumiJournal of Thoracic Oncology(2021)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要